Looking forward, the model’s utility could be further expanded by incorporating additional experimental data, particularly for longer peptides relevant to MHC class II presentation and CD4+ T-cell responses, which play critical roles in anti-tumor immunity. This evidence concerns the gene CD4 and neoplasm.